"BSA Harrington Cancer Services is dedicated to providing the most advanced cancer care and treatment in the Texas Panhandle region through the Harrington Cancer Center and the Harrington Breast Care Center. We provide a unique, team approach to provide consultation, evaluation, diagnosis, and comprehensive treatment."

During the past decade, Harrington Cancer Center conducted 45 clinical trials. In the 10-year time frame, 45 clinical trials started and 68 clinical trials were completed, i.e. on average, 151.1% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 26 clinical trials were completed. i.e. 162.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Harrington Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 47 trials, followed by "SWOG Cancer Research Network" with 47 trials sponsored, "Radiation Therapy Oncology Group" with 38 trials sponsored, "Alliance for Clinical Trials in Oncology" with 9 trials sponsored and "Gynecologic Oncology Group" with 9 trials sponsored. Other sponsors include 27 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Harrington Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 117 trials as a collaborator, "Cancer and Leukemia Group B" with 15 trials as a collaborator, "SWOG Cancer Research Network" with 15 trials as a collaborator, "NRG Oncology" with 14 trials as a collaborator and "Eastern Cooperative Oncology Group" with 10 trials as a collaborator. Other collaborators include 45 different institutions and companies that were collaborators in the rest 32 trials.

According to Clinical.Site data, the most researched conditions in "Harrington Cancer Center" are "Breast Cancer" (15 trials), "Lung Cancer" (14 trials), "Prostate Cancer" (14 trials), "Head and Neck Cancer" (12 trials) and "Recurrent Squamous Cell Lung Carcinoma" (9 trials). Many other conditions were trialed in "Harrington Cancer Center" in a lesser frequency.

Most popular intervention types in "Harrington Cancer Center" are "Drug" (147 trials), "Other" (62 trials), "Biological" (56 trials), "Radiation" (53 trials) and "Procedure" (39 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (41 trials), "radiation therapy" (35 trials), "Quality-of-Life Assessment" (20 trials), "cisplatin" (19 trials) and "paclitaxel" (18 trials). Other intervention names were less common.

The vast majority of trials in "Harrington Cancer Center" are 130 trials for "All" genders, 38 trials for "Female" genders and 14 trials for "Male" genders.

Currently, there are NaN active trials in "Harrington Cancer Center". undefined are not yet recruiting, 16 are recruiting, 39 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 111 completed trials in Harrington Cancer Center, 1 suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Harrington Cancer Center, 9 "Phase 1" clinical trials were conducted, 79 "Phase 2" clinical trials and 96 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".